Fridays vs Midi Health
Fridays and Midi Health sell different medications; this is what separates them.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Fridays
Best for: coaching bundled into the price rather than sold separately
Visit Fridays →
Midi Health
Best for: coverage in all 50 states, which most sellers will not confirm
Visit Midi Health →If you are choosing between Fridays and Midi Health, price alone will not settle it. Fridays leads our six-part score, 5.5 to 4.6.
Fridays vs Midi Health price
Fridays publishes $249 a month. Midi Health does not post a GLP-1 price we can quote, so you would only learn its cost after an intake.
Medications and formats
Fridays lists semaglutide and tirzepatide; Midi Health does not name its drug.
On format, Fridays prices compounded injections and brand-name pens, while Midi Health posts no priced format.
If you want the FDA-approved brand rather than a compounded version, Fridays is the only one of the two with a brand-name price.
Where each one treats patients
Fridays does not publish where it ships, and Midi Health lists 50 states.
Pricing
Fridays
Midi Health
Per-visit self-pay fee, NOT a monthly medication price; GLP-1 medication billed separately or through insurance. No compounded medication price is published on the current site.
Per-visit self-pay fee; medication not included. Under insurance you instead pay your standard copay + deductible.
What each price covers
Fridays' price also covers the clinician visit, the medication itself and coaching, which Midi Health does not claim.
Fridays is silent on shipping and lab work.
Midi Health does not say what its price includes.
That matters most for the drug: unless Midi Health confirms otherwise, budget for medication on top of its listed price.
Fridays
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
Not stated
Lab work
Not stated
Coaching
In the price
Midi Health
Inclusions not disclosed.
Where each one scores higher
Overall, Fridays scores 5.5 and Midi Health 4.6 out of 10.
Fridays is stronger on effectiveness (10.0 vs 5.0), user experience (3.0 vs 2.5) and support (7.0 vs 5.0).
Midi Health is stronger on trust & safety (5.0 vs 4.0) and accessibility (10.0 vs 5.0).
Value is within half a point.
Fridays
5.5/10
Midi Health
4.6/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
Neither Fridays nor Midi Health has an FDA warning letter on record with us.
Features & Coverage
| Feature | Fridays | Midi Health |
|---|---|---|
| Starting Price | $249/mo | Not published |
| Features | 2 features | ✓5 features |
| States Available | Not disclosed | 50 |
| Compounded | ✓ Yes | — |
| Brand Name | ✓ Yes | — |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | None | None |
About Fridays
Fridays is a telehealth weight loss seller running compounded GLP-1 programs.
Read our full Fridays review →About Midi Health
Medicare, Medicaid, and Medi-Cal are all refused at Midi Health, though commercial insurance is taken. The platform covers menopause and perimenopause nationwide, in 50 states. GLP-1s are not sold here as a standalone weight-loss product; a clinician may add one at their discretion, a metabolic-health adjunct inside the menopause care framework.
Read our full Midi Health review →Pros & Cons
Fridays
What we like
- The monthly price includes the medication, clinician visits and coaching
- We found no FDA warning letters issued to Fridays
Watch-outs
- Semaglutide costs $249 a month, 35% above the $184 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $359 a month, 44% above the $250 median for compounded tirzepatide across the sellers we compare
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Midi Health
What we like
- Serves all 50 states
- We found no FDA warning letters issued to Midi Health
- A live video visit with a clinician is required before a prescription, which is slower than a form and is the more careful intake
Watch-outs
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Ask which pharmacy fills the prescription before you pay, so you can check its license
Our Verdict
Fridays wins this one, 5.5 to 4.6, above all for coaching bundled into the price rather than sold separately. Midi Health fits better if coverage in all 50 states, which most sellers will not confirm is your priority.
Choose Fridays if…
You want coaching bundled into the price rather than sold separately and an opening price near $249 a month.
Choose Midi Health if…
You want coverage in all 50 states, which most sellers will not confirm.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Wellorithm
Compounded semaglutide at $247/month
From $247/mo
Get started →Willow
Seeing what it charges before you answer any medical questions
From $299/mo
Get started →Sesame Care
Oral orforglipron alongside the injectables
From $59/mo
Get started →Fridays vs Midi Health: FAQ
Close alternatives to Fridays and Midi Health
- Fridays vs Luvo Health
- Fridays vs RxSpan MD
- Fridays vs Elevated Health
- Fridays vs Better U Care
- Midi Health vs Embody
- Midi Health vs TrimRx
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.